The Siberian Scientific Medical Journal
№ 1 / 2018 / 5-11
DOI 10.15372/SSMJ20180101


Author Affiliations


The aim of the study was to determine the dose of a virulent strain of Mycobacterium tuberculosis H37Rv that is optimal for modeling experimental tuberculosis granulomatosis in mice and to investigate the effect of the original inductor of the Keap1/Nrf2/ARE system TS-13 (sodium 3- (3'-tert-butyl-4'-hydroxyphenyl) propylthiosulfonate) on animal survival and the dynamics of granuloma formation. Material and methods. Generalized tuberculosis granulomatosis was modeled by a single injection into the tail vein of male BALB/c mice of the 2-month-old M. tuberculosis strain H37Rv at doses of 106, 107 and 108 microbial bodies. Another group of animals on the day of infection with M. tuberculosis (107 microbial bodies) began to receive TS-13 with drinking water (100 mg/kg body weight). Survival was fixed daily; after 5 weeks, mice were euthanized and liver samples were taken for histological examination. Results and discussion. The dose of 107 microbial bodies was found to be the most adequate when modeling in BALB/c mice the tuberculosis granulomatosis caused by the intravenous injection of virulent M. tuberculosis strain H37Rv. At the 36th day after the injection of 107 microbial bodies, mortality was significantly lower in the group of mice receiving the inducer of the signal system Keap1/Nrf2/ARE monophenol TS-13 with drinking water (44 and 15% mice survived, respectively). At the same time, these two groups did not differ in the number and diameter of liver granulomas. The results show a high prospect of studying the role of oxidative stress and the redox-sensitive signal system Keap1/Nrf2/ARE in tuberculosis granulomatosis.

Key words

H37Rv, synthetic monophenol TS-13, Keap1/Nrf2/ARE system, tuberculosis
About Authors (Correspondence):

Menshchikova E.B. – doctor of medical sciences, head of the laboratory of molecular mechanisms of free radical processes, e-mail:

Full Text

Received: 26/02/2018
Accepted: 26/02/2018